×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Calithera (CALA) Soars: Stock Adds 9.4% in Session
Yahoo News UK
Calithera Biosciences, Inc. CALA was a big mover last session, as the company saw its shares rise more than 9% on the day.
1 day ago
StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)
Defense World
Equities researchers at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a note issued to...
3 days ago
Cash-strapped Calithera closes down in shadow of enrollment delays to cancer trials
Fierce Biotech
Calithera Biosciences has kept its head down since a phase 2 fail in 2021 caused layoffs for a third of its workforce. But in the wake of...
15 months ago
Susan Molineaux is at it again: Weeks after biotech closes, she lands as CEO of Para Therapeutics - San Francisco ...
The Business Journals
The CEO scored big with the multiple myeloma drug Kyprolis, then fizzled with Calithera. Her new company is taking another approach to...
11 months ago
Calithera Biosciences (NASDAQ:CALA) Receives New Coverage from Analysts at StockNews.com
Defense World
Read Calithera Biosciences (NASDAQ:CALA) Receives New Coverage from Analysts at StockNews.com at Defense World.
3 weeks ago
Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and ...
PR Newswire
Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037).
35 months ago
Calithera Biosciences Scores Two Complementary Oncology Compounds in Takeda Deal
BioSpace
Late Monday afternoon, South San Francisco-based Calithera secured sapanisertib (CB-228, formerly TAK-228) and mivavotinib (CB-659, formerly TAK...
30 months ago
Calithera Biosciences Inc (CALA) Q4 2020 Earnings Call Transcript
The Motley Fool
Calithera Biosciences Inc (CALA) Q4 2020 Earnings Call Mar 16, 2021, 5:00 p.m. ET. Contents: Prepared Remarks; Questions and Answers...
37 months ago
Calithera Biosciences Stock Nosedives On Complete Liquidation, Dissolution
Yahoo Finance
Calithera Biosciences Inc (NASDAQ: CALA) announced that its Board of Directors has determined that it is in the best interests of its...
15 months ago
Cancer anabolic metabolism inhibitors move into clinic
Nature
Agios Pharmaceuticals and Celgene have signed the biggest deal so far in the emerging discipline of metabolic immuno-oncology.
92 months ago